Literature DB >> 20399957

CXC chemokines in cancer angiogenesis and metastases.

Ellen C Keeley1, Borna Mehrad, Robert M Strieter.   

Abstract

The tumor microenvironment is extremely complex that depends on tumor cell interaction with the responding host cells. Angiogenesis, or new blood vessel growth from preexisting vasculature, is a preeminent feature of successful tumor growth of all solid tumors. While a number of factors produced by both the tumor cells and host responding cells have been discovered that regulate angiogenesis, increasing evidence is growing to support the important role of CXC chemokines in this process. As a family of cytokines, the CXC chemokines are pleiotropic in their ability to regulate tumor-associated angiogenesis, as well as cancer cell metastases. In this chapter, we will discuss the disparate activity that CXC chemokines play in regulating cancer-associated angiogenesis and metastases. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399957      PMCID: PMC3069502          DOI: 10.1016/S0065-230X(10)06003-3

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  118 in total

1.  The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.

Authors:  Karl Balabanian; Bernard Lagane; Simona Infantino; Ken Y C Chow; Julie Harriague; Barbara Moepps; Fernando Arenzana-Seisdedos; Marcus Thelen; Françoise Bachelerie
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

2.  CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.

Authors:  Patrick L Wagner; Elizabeth Hyjek; Madeline F Vazquez; Danish Meherally; Yi Fang Liu; Paul A Chadwick; Tatiana Rengifo; Gabriel L Sica; Jeffrey L Port; Paul C Lee; Subroto Paul; Nasser K Altorki; Anjali Saqi
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-19       Impact factor: 5.209

3.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

Authors:  Roderick J Phillips; Marie D Burdick; Marin Lutz; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

4.  Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Authors:  Joseph Kim; Hiroya Takeuchi; Stella T Lam; Roderick R Turner; He-Jing Wang; Christine Kuo; Leland Foshag; Anton J Bilchik; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

5.  Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress.

Authors:  Jianguo Du; Jing Luan; Hua Liu; Thomas O Daniel; Stephen Peiper; Theresa S Chen; Yingchun Yu; Linda W Horton; Lillian B Nanney; Robert M Strieter; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-01       Impact factor: 4.962

6.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

7.  Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space.

Authors:  Ken-Ichi Oonakahara; Wataru Matsuyama; Ikkou Higashimoto; Masaharu Kawabata; Kimiyoshi Arimura; Mitsuhiro Osame
Journal:  Am J Respir Cell Mol Biol       Date:  2003-12-12       Impact factor: 6.914

8.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.

Authors:  Zhenhua Miao; Kathryn E Luker; Bretton C Summers; Rob Berahovich; Mahaveer S Bhojani; Alnawaz Rehemtulla; Celina G Kleer; Jeffrey J Essner; Aidas Nasevicius; Gary D Luker; Maureen C Howard; Thomas J Schall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

Review 9.  Role of chemokines and their receptors in cancer.

Authors:  Roeliene C Kruizinga; Jovanka Bestebroer; Paul Berghuis; Carla J C de Haas; Thera P Links; Elisabeth G E de Vries; Annemiek M E Walenkamp
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.

Authors:  Dingzhi Wang; Haibin Wang; Joanne Brown; Takiko Daikoku; Wei Ning; Qiong Shi; Ann Richmond; Robert Strieter; Sudhansu K Dey; Raymond N DuBois
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

View more
  104 in total

Review 1.  Chronic Pancreatitis and the Development of Pancreatic Cancer.

Authors:  Hemanth K Kandikattu; Sathisha U Venkateshaiah; Anil Mishra
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

2.  microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.

Authors:  Ashraf Bakkar; Mohammed Alshalalfa; Lars F Petersen; Hatem Abou-Ouf; Amal Al-Mami; Samar A Hegazy; Felix Feng; Reda Alhajj; Krikor Bijian; Moulay A Alaoui-Jamali; Tarek A Bismar
Journal:  Mol Biol Rep       Date:  2016-02-23       Impact factor: 2.316

Review 3.  Neutrophils in the activation and regulation of innate and adaptive immunity.

Authors:  Alberto Mantovani; Marco A Cassatella; Claudio Costantini; Sébastien Jaillon
Journal:  Nat Rev Immunol       Date:  2011-07-25       Impact factor: 53.106

Review 4.  Neutrophils in innate and adaptive immunity.

Authors:  Sébastien Jaillon; Maria Rosaria Galdiero; Davide Del Prete; Marco Antonio Cassatella; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

5.  The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma.

Authors:  Juliana Romanini; Tânia R Mielcke; Paulo C Leal; Cláudia P Figueiredo; João B Calixto; Fernanda B Morrone; Eraldo L Batista; Maria M Campos
Journal:  Invest New Drugs       Date:  2011-06-14       Impact factor: 3.850

Review 6.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression.

Authors:  Oana Herlea-Pana; Longbiao Yao; Janet Heuser-Baker; Qiongxin Wang; Qilong Wang; Constantin Georgescu; Ming-Hui Zou; Jana Barlic-Dicen
Journal:  Cardiovasc Res       Date:  2015-03-12       Impact factor: 10.787

8.  The CXCL12/CXCR4 autocrine loop increases the metastatic potential of non-small cell lung cancer in vitro.

Authors:  Xiaofeng Dai; Zhifu Mao; Jie Huang; Songping Xie; Hao Zhang
Journal:  Oncol Lett       Date:  2012-10-10       Impact factor: 2.967

Review 9.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

10.  CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.

Authors:  Hai-bo Shen; Zheng-qin Gu; Kang Jian; Juan Qi
Journal:  Tumour Biol       Date:  2013-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.